+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery Outsourcing Market - Global Forecast 2025-2030- Product Image
Drug Discovery Outsourcing Market - Global Forecast 2025-2030- Product Image
Sale

Drug Discovery Outsourcing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715771
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Drug Discovery Outsourcing Market offers organizations the flexibility and expertise needed to streamline research while solving pressing challenges in early-stage therapeutics development. As companies navigate dynamic industry shifts, strategic outsourcing partnerships are emerging as critical drivers of innovation, resilience, and competitive advantage.

Market Snapshot: Drug Discovery Outsourcing Market Size and Growth

The Drug Discovery Outsourcing Market grew from USD 3.96 billion in 2024 to USD 4.29 billion in 2025. It is projected to continue its upward trajectory with a CAGR of 8.44%, reaching USD 6.45 billion by 2030. This consistent growth highlights expanding demand for outsourced research capabilities among biopharma, biotechnology firms, and service providers as organizations look to accelerate discovery, reduce costs, and gain access to specialized expertise.

Scope & Segmentation

  • Service Types: Biological services (assay development, biological testing), chemical services (custom synthesis, process R&D), and data management services (bioinformatics, data integration).
  • Discovery Phases: Lead optimization (compound screening, structure-based drug design), target identification (biomarker discovery, genomic sequencing methods).
  • Workflows: Lead identification and candidate optimization, preclinical development, target identification and screening, target validation, and functional informatics.
  • Drug Types: Large molecules (biologics and biosimilars) and small molecules with differentiated requirements for development and compliance.
  • Application Areas: Cardiovascular diseases, infectious diseases, and oncology, each demanding specialized assay systems, models, and safety evaluations.
  • End Users: Full-service and specialty contract research organizations (CROs), pharmaceutical and biotechnology companies (large enterprises and SMEs), academic institutions, and government research centers.
  • Geographic Coverage: Americas (including the US, Canada, Brazil, and more), Europe, Middle East & Africa (spanning the UK, Germany, South Africa, among others), and Asia-Pacific (covering China, India, Japan, and additional key markets).
  • Key Companies: Participation from global entities including Agilent Technologies, Charles River Laboratories, Covance, Merck & Co., Thermo Fisher Scientific, WuXi AppTec, and a diverse set of innovative CROs and biotech firms.

Key Takeaways for Senior Decision-Makers

  • Strategic outsourcing now spans entire research programs, moving beyond task-level engagements toward comprehensive, end-to-end alliances.
  • Integration of artificial intelligence, machine learning, and analytics is redefining how target identification, lead optimization, and preclinical validation are approached across the sector.
  • Regulatory agencies are setting higher standards for biologics testing, data integrity, and chemical safety, prompting service providers to enhance compliance frameworks.
  • Hybrid models that blend in-house research with outsourced expertise are gaining traction, enabling cost optimization and resource prioritization for core competencies.
  • Risk-sharing agreements and milestone-based contracts are aligning incentives and driving shared accountability in outsourced drug discovery projects.
  • Regional specialization and nearshoring trends are becoming vital as organizations seek to bolster supply chain continuity and operational resilience.

Tariff Impact on Drug Discovery Outsourcing

The introduction of new US tariff structures in 2025 has triggered significant reassessment of cross-border supply chains, particularly for specialty chemicals and biologics components. Organizations are exploring alternative sourcing, nearshoring, and regional manufacturing hubs to mitigate cost pressures. Service providers are responding with local infrastructure investments and renegotiated logistics, and sponsors are adjusting project timelines to accommodate new supply chain realities. These developments underscore the need for strategic agility and proactive supply chain planning.

Methodology & Data Sources

This report utilizes primary data from executive interviews across pharmaceutical sponsors, biotech firms, CROs, and regulatory experts. Secondary inputs include peer-reviewed industry journals, company reports, and regulatory guidelines. Market projections integrate transaction data, pipeline metrics, and validated partnership volumes, reinforced by data triangulation and trend analysis to ensure reliability.

Why This Report Matters

  • Enables senior industry leaders to benchmark outsourcing strategies, organizational models, and technology adoption against evolving global and regional trends.
  • Delivers actionable insights into navigating tariff risks, regulatory shifts, and operational challenges for more informed resource planning and supplier engagement.
  • Provides a thorough, comparative overview of segmentation drivers, regional strengths, and key player strategies to inform high-impact decision-making.

Conclusion

The Drug Discovery Outsourcing Market is evolving, shaped by new technologies, risk-sharing models, and multinational partnerships. Leaders equipped with strategic insights can drive innovation and achieve sustained business growth in an increasingly complex landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of AI-driven target identification and lead optimization platforms in outsourced drug discovery services
5.2. Integration of high-content imaging and microfluidic screening technologies in CRO assay development pipelines
5.3. Expansion of contract manufacturing organizations specializing in monoclonal antibody and biologics scale-up services
5.4. Increased utilization of CRISPR gene editing services by biotech companies through specialized CRO partnerships
5.5. Surge in cloud-based virtual screening and in silico modeling collaborations between pharma and outsourcing providers
5.6. Emergence of integrated digital twin platforms to optimize bioprocess development in outsourced manufacturing
5.7. Regulatory harmonization efforts facilitating cross-border outsourcing of preclinical and clinical drug discovery services
5.8. Rising demand for sustainable green chemistry platforms in outsourced compound synthesis and process development
5.9. Partnership models combining small biotech firms with global CRO networks to accelerate niche therapeutic discovery
5.10. Customization of patient-derived organoid and iPSC models by specialized vendors for precision oncology outsourcing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Discovery Outsourcing Market, by Service Type
8.1. Introduction
8.2. Biological Services
8.2.1. Assay Development
8.2.2. Biological Testing
8.3. Chemical Services
8.3.1. Custom Synthesis
8.3.2. Process R&D
8.4. Data Management Services
8.4.1. Bioinformatics
8.4.2. Data Integration
9. Drug Discovery Outsourcing Market, by Discovery Phase
9.1. Introduction
9.2. Lead Optimization
9.2.1. Compound Screening
9.2.2. Structure-Based Drug Design
9.3. Target Identification
9.3.1. Biomarker Discovery
9.3.2. Genomic Sequencing Methods
10. Drug Discovery Outsourcing Market, by Workflow
10.1. Introduction
10.2. Lead Identification & Candidate Optimization
10.3. Preclinical Development
10.4. Target Identification & Screening
10.5. Target Validation & Functional Informatics
11. Drug Discovery Outsourcing Market, by Drug Type
11.1. Introduction
11.2. Large Molecules
11.2.1. Biologics
11.2.2. Biosimillar
11.3. Small Molecules
12. Drug Discovery Outsourcing Market, by Application Area
12.1. Introduction
12.2. Cardiovascular Diseases
12.2.1. Heart Failure
12.2.2. Hypertension
12.3. Infectious Diseases
12.3.1. Bacterial Infections
12.3.2. Viral Infections
12.4. Oncology
12.4.1. Hematological Malignancies
12.4.2. Solid Tumors
13. Drug Discovery Outsourcing Market, by End User
13.1. Introduction
13.2. Contract Research Organizations
13.2.1. Full-Service CROs
13.2.2. Specialty CROs
13.3. Pharmaceutical & Biotechnology Companies
13.3.1. Large Enterprises
13.3.2. SMEs
13.4. Research Institutes
13.4.1. Academic Institutions
13.4.2. Government Research Centers
14. Americas Drug Discovery Outsourcing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Drug Discovery Outsourcing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Drug Discovery Outsourcing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Agilent Technologies Inc.
17.3.2. Aragen Life Sciences Ltd.
17.3.3. BPS Bioscience, Inc.
17.3.4. Celentyx Ltd.
17.3.5. Charles River Laboratories International, Inc.
17.3.6. Covance, Inc.
17.3.7. Crown Bioscience, Inc.
17.3.8. Curia Global, Inc.
17.3.9. Dalton Pharma Services
17.3.10. Eurofins Scientific
17.3.11. Evotec SE
17.3.12. Explicyte
17.3.13. GenScript Biotech Corporation
17.3.14. HD Biosciences Co., Ltd.
17.3.15. IQVIA
17.3.16. Jubilant Biosys Ltd.
17.3.17. Laboratory Corporation of America Holdings
17.3.18. Merck & Co., Inc.
17.3.19. Oncodesign Services
17.3.20. Personalis, Inc.
17.3.21. Pfizer Inc.
17.3.22. PPD Inc.
17.3.23. Promega Corporation
17.3.24. Revvity Discovery Limited
17.3.25. Sanofi S.A.
17.3.26. STC Biologics Inc.
17.3.27. Syngene International Ltd.
17.3.28. TCG Lifesciences Pvt. Limited
17.3.29. Thermo Fisher Scientific Inc.
17.3.30. WuXi AppTec Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG DISCOVERY OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DRUG DISCOVERY OUTSOURCING MARKET: RESEARCHAI
FIGURE 28. DRUG DISCOVERY OUTSOURCING MARKET: RESEARCHSTATISTICS
FIGURE 29. DRUG DISCOVERY OUTSOURCING MARKET: RESEARCHCONTACTS
FIGURE 30. DRUG DISCOVERY OUTSOURCING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG DISCOVERY OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ASSAY DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ASSAY DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CUSTOM SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CUSTOM SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PROCESS R&D, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PROCESS R&D, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA INTEGRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COMPOUND SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COMPOUND SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STRUCTURE-BASED DRUG DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STRUCTURE-BASED DRUG DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GENOMIC SEQUENCING METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GENOMIC SEQUENCING METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & CANDIDATE OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & CANDIDATE OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION & SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION & SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET VALIDATION & FUNCTIONAL INFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET VALIDATION & FUNCTIONAL INFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOSIMILLAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOSIMILLAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SPECIALTY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SPECIALTY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 203. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 204. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 205. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 206. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 207. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 208. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 209. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 210. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 211. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2018-2024 (USD MILLION)
TABLE 212. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2025-2030 (USD MILLION)
TABLE 213. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 214. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 215. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 216. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 217. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 218. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 219. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 220. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 221. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2018-2024 (USD MILLION)
TABLE 222. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2025-2030 (USD MILLION)
TABLE 223. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 224. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 225. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 226. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 227. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 228. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 229. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 230. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 231. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 234. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 235. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 236. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 237. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 238. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 239. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 242. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 243. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 244. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 245. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 246. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 250. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 251. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 252. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 253. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 254. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 255. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2018-2024 (USD MILLION)
TABLE 258. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2025-2030 (USD MILLION)
TABLE 259. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 260. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 261. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 262. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 263. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 264. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 265. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 272. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 273. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 274. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMICAL SERVICES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DATA MANAGEMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DISCOVERY PHASE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LARGE MOLECULES, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug Discovery Outsourcing market report include:
  • Agilent Technologies Inc.
  • Aragen Life Sciences Ltd.
  • BPS Bioscience, Inc.
  • Celentyx Ltd.
  • Charles River Laboratories International, Inc.
  • Covance, Inc.
  • Crown Bioscience, Inc.
  • Curia Global, Inc.
  • Dalton Pharma Services
  • Eurofins Scientific
  • Evotec SE
  • Explicyte
  • GenScript Biotech Corporation
  • HD Biosciences Co., Ltd.
  • IQVIA
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Oncodesign Services
  • Personalis, Inc.
  • Pfizer Inc.
  • PPD Inc.
  • Promega Corporation
  • Revvity Discovery Limited
  • Sanofi S.A.
  • STC Biologics Inc.
  • Syngene International Ltd.
  • TCG Lifesciences Pvt. Limited
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.45 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Large Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening, Target Validation & Functional Informatics), By Service, By Therapeutics Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Large Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening, Target Validation & Functional Informatics), By Service, By Therapeutics Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market - Global Forecast 2025-2030 - Product Image

Cancer Immunotherapy Drug Discovery Outsourcing Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Small Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening, Preclinical Development), By Service, By Therapeutics Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Small Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow (Target Identification & Screening, Preclinical Development), By Service, By Therapeutics Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 120 Pages
  • Global
From
Drug Discovery Outsourcing Market Report 2025 - Product Image

Drug Discovery Outsourcing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drug Discovery Outsourcing - Global Strategic Business Report - Product Image

Drug Discovery Outsourcing - Global Strategic Business Report

  • Report
  • 390 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.